Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $908000.0.

  • Cytosorbents' Other Working Capital Changes rose 2850.11% to $908000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 54477.37%. This contributed to the annual value of $797209.0 for FY2024, which is 7058.73% up from last year.
  • Latest data reveals that Cytosorbents reported Other Working Capital Changes of $908000.0 as of Q3 2025, which was up 2850.11% from $187177.0 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Other Working Capital Changes registered a high of $1.9 million during Q4 2024, and its lowest value of -$307097.0 during Q1 2022.
  • Its 5-year average for Other Working Capital Changes is $431142.8, with a median of $266343.0 in 2023.
  • Per our database at Business Quant, Cytosorbents' Other Working Capital Changes plummeted by 17068.76% in 2021 and then surged by 101638.19% in 2022.
  • Over the past 5 years, Cytosorbents' Other Working Capital Changes (Quarter) stood at $962664.0 in 2021, then soared by 58.4% to $1.5 million in 2022, then tumbled by 82.53% to $266343.0 in 2023, then skyrocketed by 597.15% to $1.9 million in 2024, then tumbled by 51.1% to $908000.0 in 2025.
  • Its Other Working Capital Changes was $908000.0 in Q3 2025, compared to $187177.0 in Q2 2025 and $34781.0 in Q1 2025.